Dr Panos Kottaridis is a Consultant Haematologist in Leukaemia and Bone Marrow Transplantation at University College London Hospitals NHS.

His main academic and clinical interests focus on prognostication of acute myeloid leukaemia (AML), bone marrow transplantation, late effects of chemotherapy/ bone marrow transplantation, fertility in recipients of chemotherapy and immunotherapy of haematological malignancies (i.e. monoclonal antibodies, CAR-T cells).

Dr Kottaridis is a member of the National Cancer Research Network (Former MRC) working party for AML. He has published more than 74 papers in peer-reviewed journals and more than 4000 scientific papers have cited his work; he has also contributed with two chapters in Haematology textbooks.

Dr Kottaridis is an enthusiastic teacher and lecturer having given more than 200 lectures and presentations in national and international meetings.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Diseases, Medical Tests and Treatments

• Bone Marrow Transplantation
• Immunotherapy
• Acute Myeloid Leukaemia (AML)
• Bone Marrow Transplantation
• Treating Haematological Malignancies with Immunotherapy
• Late Effects of Chemotherapy/ Bone Marrow Transplantation
• Fertility in Recipients of Chemotherapy